{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:57:54Z","timestamp":1790629074104,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"DOI":"10.1007\/s10557-026-07966-4","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:04:35Z","timestamp":1790582675000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Herpes Zoster Vaccination as Cardiovascular Prevention in Adults with Heart Disease"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1402-4364","authenticated-orcid":false,"given":"Lorenzo","family":"Facila Rubio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-6078","authenticated-orcid":false,"given":"Vicente","family":"Pallar\u00e9s-Carratal\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0000-7109","authenticated-orcid":false,"given":"Alberto","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7380-3475","authenticated-orcid":false,"given":"Jos\u00e9","family":"P\u00e9rez Silvestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8665-7107","authenticated-orcid":false,"given":"Clara","family":"Bonanad Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"7966_CR1","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1093\/eurheartj\/ehaf384","volume":"46","author":"B Heidecker","year":"2025","unstructured":"Heidecker B, Libby P, Vassiliou VS, et al. Vaccination as a new form of cardiovascular prevention: a European Society of Cardiology clinical consensus statement. Eur Heart J. 2025;46:3518\u201331. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf384.","journal-title":"Eur Heart J"},{"key":"7966_CR2","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.jacc.2025.07.003","volume":"86","author":"PA Heidenreich","year":"2025","unstructured":"Heidenreich PA, Bhatt A, Nazir NT, Schaffner W, Vardeny O. 2025 concise clinical guidance: an ACC expert consensus statement on adult immunizations as part of cardiovascular care. J Am Coll Cardiol. 2025;86:2085\u201398. https:\/\/doi.org\/10.1016\/j.jacc.2025.07.003","journal-title":"J Am Coll Cardiol"},{"key":"7966_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2026.07.004","author":"PA Heidenreich","year":"2026","unstructured":"Heidenreich PA, Bhatt A, Nazir NT, Schaffner W, Vardeny O. Adult Immunizations as Part of Cardiovascular Care: 2026 ACC Concise Clinical Guidance. J Am Coll Cardiol. 2026. https:\/\/doi.org\/10.1016\/j.jacc.2026.07.004. published online 5 August.","journal-title":"J Am Coll Cardiol"},{"key":"7966_CR4","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.3390\/jcm15145343","volume":"15","author":"C Bonanad","year":"2026","unstructured":"Bonanad C, Barrios V, Barreres G, Maidana D, Redondo E. Influenza Vaccination as Cardiovascular Prevention in Adults with Heart Disease. J Clin Med. 2026;15:5343. https:\/\/doi.org\/10.3390\/jcm15145343.","journal-title":"J Clin Med"},{"key":"7966_CR5","volume-title":"Recomendaciones de vacunaci\u00f3n frente a herpes z\u00f3ster [Herpes zoster vaccination recommendations]","author":"Working Group on Herpes Zoster Vaccination, Public Health Commission of the Interterritorial Council of the Spanish National Health System","year":"2021","unstructured":"Working Group on Herpes Zoster Vaccination, Public Health Commission of the Interterritorial Council of the Spanish National Health System. Recomendaciones de vacunaci\u00f3n frente a herpes z\u00f3ster [Herpes zoster vaccination recommendations]. Madrid, Spain: Spanish Ministry of Health; 2021. updated 2023 and 2025."},{"key":"7966_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","volume":"4","author":"C Baethge","year":"2019","unstructured":"Baethge C, Goldbeck-Wood S, Mertens S. SANRA\u2014a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4:5. https:\/\/doi.org\/10.1186\/s41073-019-0064-8.","journal-title":"Res Integr Peer Rev"},{"key":"7966_CR7","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"7966_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-026-04606-0","author":"F Corsi-Zuelli","year":"2026","unstructured":"Corsi-Zuelli F, Li F, Upthegrove R, et al. Recombinant shingles vaccination and the risk of cardiovascular events. Nat Med. 2026. https:\/\/doi.org\/10.1038\/s41591-026-04606-0.","journal-title":"Nat Med"},{"key":"7966_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-026-02786-3","author":"CA Wang","year":"2026","unstructured":"Wang CA, Wang WJ, Liao HW, et al. Recombinant zoster vaccine and risk of kidney failure, cardiovascular, and mortality in patients with chronic kidney disease. Hypertens Res. 2026. https:\/\/doi.org\/10.1038\/s41440-026-02786-3.","journal-title":"Hypertens Res"},{"key":"7966_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/jcm8040547","volume":"8","author":"PH Wu","year":"2019","unstructured":"Wu PH, Chuang YS, Lin YT. Does Herpes Zoster Increase the Risk of Stroke and Myocardial Infarction? A Comprehensive Review. J Clin Med. 2019;8:547. https:\/\/doi.org\/10.3390\/jcm8040547.","journal-title":"J Clin Med"},{"key":"7966_CR11","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1093\/infdis\/jiy385","volume":"218","author":"C Warren-Gash","year":"2018","unstructured":"Warren-Gash C. Herpes Zoster: Epidemiological Links With Stroke and Myocardial Infarction. J Infect Dis. 2018;218:S102\u20136.","journal-title":"J Infect Dis"},{"key":"7966_CR12","doi-asserted-by":"publisher","first-page":"e0181565","DOI":"10.1371\/journal.pone.0181565","volume":"12","author":"N Erskine","year":"2017","unstructured":"Erskine N, Tran H, Levin L, et al. A systematic review and meta-analysis on herpes zoster and the risk of cardiac and cerebrovascular events. PLoS ONE. 2017;12:e0181565. https:\/\/doi.org\/10.1371\/journal.pone.0181565.","journal-title":"PLoS ONE"},{"key":"7966_CR13","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.04.013","volume":"26","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Luo G, Huang Y, Yu Q, Wang L, Li K. Risk of Stroke\/Transient Ischemic Attack or Myocardial Infarction with Herpes Zoster: A Systematic Review and Meta-Analysis. J Stroke Cerebrovasc Dis. 2017;26:1807\u201316. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.04.013.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"7966_CR14","doi-asserted-by":"publisher","first-page":"e2556","DOI":"10.1002\/rmv.2556","volume":"34","author":"M Heiat","year":"2024","unstructured":"Heiat M, Salesi M, Peypar MH, Ramazani A, Abdorrashidi M, Yeganeh AV. A comprehensive, updated systematic review and meta-analysis of epidemiologic evidence on the connection between herpes zoster infection and the risk of stroke. Rev Med Virol. 2024;34:e2556. https:\/\/doi.org\/10.1002\/rmv.2556.","journal-title":"Rev Med Virol"},{"key":"7966_CR15","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/cid\/ciu098","volume":"58","author":"SM Langan","year":"2014","unstructured":"Langan SM, Minassian C, Smeeth L, Thomas SL. Risk of Stroke Following Herpes Zoster: A Self-Controlled Case-Series Study. Clin Infect Dis. 2014;58:1497\u2013503. https:\/\/doi.org\/10.1093\/cid\/ciu098.","journal-title":"Clin Infect Dis"},{"key":"7966_CR16","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1161\/STROKEAHA.109.562017","volume":"40","author":"JH Kang","year":"2009","unstructured":"Kang JH, Ho JD, Chen YH, Lin HC. Increased risk of stroke after a herpes zoster attack: a population-based follow-up study. Stroke. 2009;40:3443\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.109.562017.","journal-title":"Stroke"},{"key":"7966_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jacc.2017.05.015","volume":"70","author":"MC Kim","year":"2017","unstructured":"Kim MC, Yun SC, Lee HB, et al. Herpes zoster increases the risk of stroke and myocardial infarction. J Am Coll Cardiol. 2017;70:295\u20136. https:\/\/doi.org\/10.1016\/j.jacc.2017.05.015.","journal-title":"J Am Coll Cardiol"},{"key":"7966_CR18","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1093\/eurheartj\/ehaf230","volume":"46","author":"S Lee","year":"2025","unstructured":"Lee S, Lee K, Oh J, et al. Live zoster vaccination and cardiovascular outcomes: a nationwide, South Korean study. Eur Heart J. 2025;46:2991\u20133002. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf230.","journal-title":"Eur Heart J"},{"key":"7966_CR19","doi-asserted-by":"publisher","first-page":"e1001919","DOI":"10.1371\/journal.pmed.1001919","volume":"12","author":"C Minassian","year":"2015","unstructured":"Minassian C, Thomas SL, Smeeth L, Douglas I, Brauer R, Langan SM. Acute cardiovascular events after herpes zoster: a self-controlled case series analysis in vaccinated and unvaccinated older residents of the United States. PLoS Med. 2015;12:e1001919. https:\/\/doi.org\/10.1371\/journal.pmed.1001919.","journal-title":"PLoS Med"},{"key":"7966_CR20","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1161\/STROKEAHA.120.032788","volume":"52","author":"Q Yang","year":"2021","unstructured":"Yang Q, Chang A, Tong X, Merritt R. Herpes zoster vaccine live and risk of stroke among Medicare beneficiaries: a population-based cohort study. Stroke. 2021;52:1712\u201321. https:\/\/doi.org\/10.1161\/STROKEAHA.120.032788.","journal-title":"Stroke"},{"key":"7966_CR21","unstructured":"European Medicines Agency. Zostavax: withdrawal of the marketing authorisation in the European Union. 2025."},{"key":"7966_CR22","doi-asserted-by":"publisher","first-page":"1176920","DOI":"10.3389\/fneur.2023.1176920","volume":"14","author":"Y-H Jia","year":"2023","unstructured":"Jia Y-H, Dong Y-B, Jiang H-Y, Li A-J. Effects of herpes zoster vaccination and antiviral treatment on the risk of stroke: a systematic review and meta-analysis. Front Neurol. 2023;14:1176920.","journal-title":"Front Neurol"},{"issue":"Suppl 1","key":"7966_CR23","doi-asserted-by":"publisher","first-page":"ehaf7843633","DOI":"10.1093\/eurheartj\/ehaf784.3633","volume":"46","author":"C Williams","year":"2025","unstructured":"Williams C, Bhatt DL, Aguiar C, Nguyen TYC, Antoniou E, Parikh R. Herpes zoster vaccine effectiveness against cardiovascular events\u2014a systematic literature review and meta-analysis. Eur Heart J. 2025;46(Suppl 1):ehaf7843633. ESC Congress 2025 abstract; funded by GSK.","journal-title":"Eur Heart J"},{"key":"7966_CR24","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0000000000001243","author":"MT Maniya","year":"2026","unstructured":"Maniya MT, Farid AAM, Abid H, et al. Cardiovascular outcomes following herpes zoster vaccination: a systematic review and meta-analysis. Cardiol Rev. 2026. https:\/\/doi.org\/10.1097\/CRD.0000000000001243.","journal-title":"Cardiol Rev"},{"key":"7966_CR25","doi-asserted-by":"publisher","first-page":"ofad137","DOI":"10.1093\/ofid\/ofad137","volume":"10","author":"GI Parameswaran","year":"2023","unstructured":"Parameswaran GI, Drye A, Wattengel B, et al. Increased myocardial infarction risk following herpes zoster infection. Open Forum Infect Dis. 2023;10:ofad137. https:\/\/doi.org\/10.1093\/ofid\/ofad137.","journal-title":"Open Forum Infect Dis"},{"key":"7966_CR26","doi-asserted-by":"publisher","first-page":"e1335","DOI":"10.1093\/cid\/ciac549","volume":"76","author":"GI Parameswaran","year":"2023","unstructured":"Parameswaran GI, Wattengel BA, Chua HC, et al. Increased stroke risk following herpes zoster infection and protection with zoster vaccine. Clin Infect Dis. 2023;76:e1335\u201340. https:\/\/doi.org\/10.1093\/cid\/ciac549.","journal-title":"Clin Infect Dis"},{"key":"7966_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/aje\/kwac170","volume":"192","author":"JC Nelson","year":"2023","unstructured":"Nelson JC, Ulloa-P\u00e9rez E, Yu O, et al. Active postlicensure safety surveillance for recombinant zoster vaccine using electronic health record data. Am J Epidemiol. 2023;192:205\u201316. https:\/\/doi.org\/10.1093\/aje\/kwac170.","journal-title":"Am J Epidemiol"},{"key":"7966_CR28","doi-asserted-by":"publisher","first-page":"e70285","DOI":"10.1002\/jmv.70285","volume":"97","author":"PC Shih","year":"2025","unstructured":"Shih PC, Wang SI, Leong PY, et al. Recombinant zoster vaccine reduces all-cause mortality, but not major adverse cardiovascular events, in patients with immune-mediated inflammatory diseases receiving Janus kinase inhibitors: a large-scale real-world retrospective cohort study. J Med Virol. 2025;97:e70285. https:\/\/doi.org\/10.1002\/jmv.70285.","journal-title":"J Med Virol"},{"key":"7966_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/infdis\/jiaf105","volume":"232","author":"X Xu","year":"2025","unstructured":"Xu X, Ray I, Tang E, Arnold BF, Acharya NR. Protective effects of recombinant zoster vaccine and antiviral therapy against cardiovascular disease following herpes zoster infection. J Infect Dis. 2025;232:465\u201373. https:\/\/doi.org\/10.1093\/infdis\/jiaf105.","journal-title":"J Infect Dis"},{"key":"7966_CR30","doi-asserted-by":"crossref","unstructured":"Nguyen R, Desai A. Herpes Zoster Vaccination and Risk of Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease. Presented at ACC.26, American College of Cardiology Annual Scientific Session; 28\u201330 March 2026; New Orleans. Abstract\/poster, not yet published as a full article.","DOI":"10.1016\/j.jacc.2026.02.547"},{"key":"7966_CR31","doi-asserted-by":"publisher","first-page":"e090428","DOI":"10.1136\/bmjopen-2024-090428","volume":"15","author":"E Kornelius","year":"2025","unstructured":"Kornelius E, Lo SC, Huang CN, Wang CC, Wang YH, Yang YS. Association of herpes zoster vaccination and cardiovascular risk in patients with diabetes: long-term insights from a retrospective cohort study. BMJ Open. 2025;15:e090428. https:\/\/doi.org\/10.1136\/bmjopen-2024-090428.","journal-title":"BMJ Open"},{"key":"7966_CR32","doi-asserted-by":"publisher","first-page":"103319","DOI":"10.1016\/j.eclinm.2025.103319","volume":"85","author":"YL Lin","year":"2025","unstructured":"Lin YL, Wang SI, Wei JCC. Effectiveness of recombinant zoster vaccine in reducing herpes zoster incidence and all-cause mortality among patients with rheumatoid arthritis: a retrospective cohort study of 21,046 individuals from TriNetX U.S. Collaborative Network. EClinicalMedicine. 2025;85:103319. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103319.","journal-title":"EClinicalMedicine"},{"key":"7966_CR33","doi-asserted-by":"publisher","unstructured":"Dehghani A, Yendewa G. 402. Zoster Vaccination in people living with HIV is associated with reduced mortality and cardiovascular risk: A real-world matched cohort study. Open Forum Infect Dis. 2026;13(Suppl 1):ofaf695.140 https:\/\/doi.org\/10.1093\/ofid\/ofaf695.140.","DOI":"10.1093\/ofid\/ofaf695.140"},{"key":"7966_CR34","doi-asserted-by":"publisher","unstructured":"Dehghani A, Yendewa G. 218. Impact of prior zoster vaccination on cardiovascular, dementia, and mortality outcomes following herpes zoster infection: A matched cohort study. Open Forum Infect Dis. 11 Jan 2026;13(Suppl 1):ofaf695.076. PMCID: PMC12791287. https:\/\/doi.org\/10.1093\/ofid\/ofaf695.076.","DOI":"10.1093\/ofid\/ofaf695.076"},{"key":"7966_CR35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1177\/17474930251380184","volume":"21","author":"A Yahav","year":"2026","unstructured":"Yahav A, Ryan D, Naftali J, et al. Association between live herpes-zoster vaccine and stroke risk: a population-based nested case-control study. Int J Stroke. 2026;21:457\u201365. https:\/\/doi.org\/10.1177\/17474930251380184.","journal-title":"Int J Stroke"},{"key":"7966_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","volume":"67","author":"KL Dooling","year":"2018","unstructured":"Dooling KL, Guo A, Patel M, Lee GM, Moore K, Belongia EA, Harpaz R. Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. MMWR Morb Mortal Wkly Rep. 2018;67:103\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"7966_CR37","volume-title":"Herpes zoster (shingles) vaccine: Canadian Immunization Guide","author":"Public Health Agency of Canada","year":"2025","unstructured":"Public Health Agency of Canada. Herpes zoster (shingles) vaccine: Canadian Immunization Guide. Ottawa, Canada: Government of Canada; 2025."},{"key":"7966_CR38","unstructured":"NHS England. Introduction of Shingrix\u00ae vaccine for the whole programme and expansion of eligible cohorts. 2023."},{"key":"7966_CR39","unstructured":"Australian Government Department of Health. Disability and Ageing. National Immunisation Program\u2014changes to shingles vaccination from 1 November 2023."},{"key":"7966_CR40","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372:2087\u201396. https:\/\/doi.org\/10.1056\/NEJMoa1501184.","journal-title":"N Engl J Med"},{"key":"7966_CR41","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham AL, Lal H, Kovac M, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N Engl J Med. 2016;375:1019\u201332. https:\/\/doi.org\/10.1056\/NEJMoa1603800.","journal-title":"N Engl J Med"},{"key":"7966_CR42","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/cid\/ciab629","volume":"74","author":"C Boutry","year":"2022","unstructured":"Boutry C, Hastie A, Diez-Domingo J, et al. The adjuvanted recombinant zoster vaccine confers long-term protection against herpes zoster: interim results of an extension study of the pivotal phase 3 clinical trials ZOE-50 and ZOE-70. Clin Infect Dis. 2022;74:1459\u201367. https:\/\/doi.org\/10.1093\/cid\/ciab629.","journal-title":"Clin Infect Dis"},{"key":"7966_CR43","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3390\/vaccines13101073","volume":"13","author":"M Chiavarini","year":"2025","unstructured":"Chiavarini M, Bechini A, Boccalini S, et al. Vaccination against herpes zoster in adults: current strategies in European Union countries. Vaccines. 2025;13:1073. https:\/\/doi.org\/10.3390\/vaccines13101073.","journal-title":"Vaccines"},{"key":"7966_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13075-025-03565-0","volume":"27","author":"JR Curtis","year":"2025","unstructured":"Curtis JR, Conrad DM, Krueger WS, et al. Real-world data on the use of the Shingrix vaccine among patients with inflammatory arthritis and risk of cardiovascular events following herpes zoster. Arthritis Res Ther. 2025;27:108. https:\/\/doi.org\/10.1186\/s13075-025-03565-0.","journal-title":"Arthritis Res Ther"},{"key":"7966_CR45","doi-asserted-by":"publisher","first-page":"555","DOI":"10.3345\/cep.2021.01564","volume":"65","author":"YH Lee","year":"2022","unstructured":"Lee YH, Choe YJ, Lee J, Kim E, Lee JY, Hong K, Yoon Y, Kim YK. Global varicella vaccination programs. Clin Exp Pediatr. 2022;65:555\u201362.","journal-title":"Clin Exp Pediatr"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07966-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-026-07966-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07966-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:02:33Z","timestamp":1790625753000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-026-07966-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":45,"alternative-id":["7966"],"URL":"https:\/\/doi.org\/10.1007\/s10557-026-07966-4","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"13 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable. This is a narrative review of previously published literature and did not involve the collection of new patient data or any intervention on human subjects.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the corresponding author (L.F.R.) used the large language model Claude (Anthropic) to assist with exploratory literature search and drafting of the manuscript, including its revision in response to peer review, as described in\n                      \n                      . All authors subsequently reviewed, independently verified, and edited the content, and take full responsibility for the scientific accuracy and integrity of the final version.","order":2,"name":"Ethics","label":"Declaration of Generative AI and AI-Assisted Technologies","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}